国際学会招聘講演・発表

招聘講演・発表

 

2023年

    招聘講演

    1. Onishi H:Expanding Role of Sterotactic Body Radiation Therapy (SBRT)for Primary and Metastatic Lesions in Not Only Medically Inoperable But Also Operable Patients. The 8th Annual Taiwan-Japan Radiation Oncology Symposium, 2023. 8.26, Taiwan.
    2. Morisaka H:Updated HCC Disease Status and Diagnostic Guideline in Japan. Asia Pacific Liver Imaging Symposium, 2023. 9.1-9.2, Bangkok, Thailand.

    発表

    1. Araki T, Okada H, Sasaki Y, Imaimatsu H, Fujihara K, Onishi H:How Frequent are Portosystemic Shunts (PSS) in Patients Without Liver Dysfunction? -Second Report. CIRSE 2023, 2023. 9.9-9.13, Copenhagen.

     

    2022年

      招聘講演

       

      発表

      1. Satoh Y,Imai M,Ikegawa C,Hiroshi Onishi:Image quality evaluation of real low-dose breast PET. SNMMI 2022 Annual Meeting, 2022. 6.11-6.14, Vancouver, Canada.
      2. Satoh Y,Imai M,Ikegawa C,Hirata K,Abo N,Kusuzaki N,Oyama-Manabe N,
        Onishi H :Effects of out-of-field radioactivity on dedicated breast PET images. EANM ’22-Annual Congress of the European Association of Nuclear Medicine, 2022. 10.15-19, Barcelona, Spain.

       

      2021年

        招聘講演

           

          発表

          1. Satoh Y, Imai M, Hirata K, Asakawa Y, C I, Onishi H:Optimal relaxation parameters of dynamic row-action maximum likelihood algorithm and post-smoothing filter for image reconstruction of dedicated breast PET. SNMMI 2021 Virtual Annual Meeting, 2021. 6.11-15, Online開催(USA).
          2. Satoh Y, Funayama S, Imai M, H O:Semi-automated histogram analysis of physiological uptake in bone marrow by 18F-FDG PET/CT. EANM ’21-Annual Congress of the European Association of Nuclear Medicine, 2021. 10.20-10.23, Online開催.
          3. Araki T, Okada H, Imaizumi A, Sasaki Y, Imaimatsu H, Onishi H:Frequency of portosystemic shunt in patients without liver dysfunction. CIRSE 2021, 2021. 9.25-9.28, オンデマンド配信.

           

           

          2020年

          招聘講演

          1. Tamada D:Breathing Artifacts in Liver MRI: Emerging Solutions. ISMRM & SMRT Virtual Conference & Exhibition (ISMRM 28th Annual Meeting & Exhibition), 2020. 8.8-14, Web.

           

          発表

          1. Ichikawa S, Oishi N, Kondo T, Onishi H:Rare Diseases of the Gallbladder and Cystic Duct: A Pictorial Essay. The 106th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA 2020), 2020. 11.29-12.5, Web.
          2. Cunha GM, Sirlin CB, Fowler KJ, Ichikawa S, Medina PMD, Hasenstab K, Lee MH, Kim SJ, Schlein AN, Delgado TI, Lee YH:Agreement for Rim versus Non-rim APHE as Features of LI-RADS on Multiarterial Phase MRI. The 106th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA 2020), 2020. 11.29-12.5, Web.
          3. Medina PMD, Sirlin CB, Fowler KJ, An JY, Ichikawa S, Pecorelli A, Cunha GM:Follow-up Outcomes of Hyperintense Distinctive Nodules in the Liver Detected on Hepatobiliary Phase Gadoxetic Acid Abbreviated MRI in a Cirrhotic Surveillance Population. The 106th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA 2020), 2020. 11.29-12.5, Web.
          4. Onishi H, al. e:Phase I Trial of The Combined Treatment of Nivolumab and Stereotactic Body Radiotherapy for Patients with Metastatic Non-Small Cell Lung Cancer. 2020 ASTRO’s 62nd Annual Meeting, 2020. 10.24-11.30,
          5. Vu N, Saito M, Sano N, Kuriyama K, Marino K, Aoki S, Onishi H:The changes in tumor volume and location during stereotactic body radiotherapy period in patients with stage I non-small cell lung cancer: the need for implementation of the Adaptive Radiotherapy planning. 2020 ASTRO’s 62nd Annual Meeting, 2020. 10.24-11.30, Web.
          6. Tamada D, Wang X, Hernando D, Reeder SB:Multiparameter mapping of T2, R2*, fat fraction using a combination of chemical shift imaging and phase-based T2 mapping. ISMRM & SMRT Virtual Conference & Exhibition (ISMRM 28th Annual Meeting & Exhibition), 2020. 8.8-14, Web.
          7. Tamada D, Wang X, Colgan TJ, Hernando D, Reeder SB:Investigation on the estimation performance of phase-based T2 mapping in the presence of motion. ISMRM & SMRT Virtual Conference & Exhibition, 2020. 8.8-14, Web.
          8. Kose K, Kose R, Terada Y, Tamada D, Motosugi U:Development of a method for Bloch image simulation of living tissues. ISMRM & SMRT Virtual Conference & Exhibition, 2020. 8.8-14, Web.
          9. Kawamura M, Tamada D, Wakayama T, Onishi H, Motosugi U:Retrospective Motion Artifact Reduction with CNN (MARC) combined with model-based artifact simulation for T2WI of the liver. ISMRM & SMRT Virtual Conference & Exhibition, 2020. 8.8-14, Web.
          10. Omiya Y, Wakayama T, Tamada D, Sagar M, Cashen TA, Onishi H, Motosugi U:Perfusion analyses of breast benign and malignant lesions using super high frame rate reconstruction with stack-of-stars acquisition. ISMRM & SMRT Virtual Conference & Exhibition, 2020. 8.8-14, Web.
          11. Kojima S, Tamada D, Ichikawa S, Morisaka H, Suzuki S, Motosugi U:Erasing artifacts from arterial phase MRI: Motion Artifact Reduction using a Convolutional network (MARC). ISMRM & SMRT Virtual Conference & Exhibition, 2020. 8.8-14, Web.
          12. Ichikawa S, Tamada D, Wakayama T, Mandaba S, Cashen TA, Onishi H, Motosugi U:Utility of Stack-of-stars Acquisition for Arterial Phase Imaging without Breath-holding on Dynamic MRI of the Liver. ISMRM & SMRT Virtual Conference & Exhibition, 2020. 8.8-14, Web.
          13. Funayama S, Wakayama T, Onishi H, Motosugi U:FITs-CNN: A Very Deep Cascaded Convolutional Neural Networks Using Folded Image Training Strategy for Abdominal MRI Reconstruction. ISMRM & SMRT Virtual Conference & Exhibition, 2020. 8.8-14, Web. 【Abstract accepted for ISMRM Travel Award of JSMRM】
          14. Roberts NT, Hernando D, Colgan TJ, Tamada D, Reeder SB:Simultaneous B1- and Fat-Corrected T1 Mapping Using Chemical-Shift Encoded MRI. ISMRM & SMRT Virtual Conference & Exhibition, 2020. 8.8-14, Web.
          15. Funayama S, Wakayama T, Lebel R, Tamada D, Onishi H, Motosugi U:High resolution T2-weighted MRI of the abdomen using deep learning reconstruction. ECR 2020, 2020. 7.15-19, Web.【Abstract accepted for invest in the youth of ECR2020】
          16. Saito M, Komiyama T, Marino K, Aoki S, Maehata Y, Matsuda M, Akita T, Suzuki H, Ueda K, Onishi H:Comparison of five types of adaptive X-ray treatment planning technique for locally advanced non-small cell lung cancer. AAPM 2020 (American Association of Physicists in Medicine), 2020. 7.12-16, Web.
          17. Satoh Y, Sekine T, Omiya Y, Onishi H, Motosugi U:Dose reduction in 18F-FDG high-resolution dedicated breast PET. SNMMI 2020 Annual Meeting, 2020. 7.11-14, Web.

           

          2019年

          招聘講演

          1. Onishi H:SBRT for  other diseases. HICARE/IAEA International Training Course on Advanced Radiation Therapy (IAEA-RCA Regional Training Course), 2019. 2.18-21, Hiroshima.
          2. Onishi H:Summary of PACFIC trial and its discussion points from the radiation oncology view. The 7th Japan-Taiwan Radiation Oncology Symposium, 2019. 5.11, Odaiba, Tokyo.
          3. Onishi H:ODAIBA-Declaration: Expand the role of SBRT toward  operable, palliative, and polymetastatic patients!」. The 7th Japan-Taiwan Radiation Oncology Symposium, 2019. 5.11, Odaiba, Tokyo.
          4. Motosugi U:Advances in Body MRI with SIGNA™ Premier and AIR Technology™. SIGNA™ MR @ ISMRM 2019 (Gold Corporate Lunch Symposium), 2019. 5.11-16, Montreal, Canada.
          5. Motosug U:MR elastography of the liver: principle and application. German Radiology Congress, 2019. 5.29-6. 1, Leipzig, Germany.

           

          発表

          1. Komiyama T, Muramatsu J, Marino K, Aoki S, Saito R, Maehata Y, Saito M, Yamada T, Akita T, Onishi H:The results of dose escalated stereotactic body radiotherapy for non-small cell lung cancer over 3.0cm. The 7th Japan-Taiwan Radiation Oncology Symposium, 2019. 5.11, Odaiba, Tokyo.
          2. Maehata Y, Satani K, Komiyama T, Marino K, Aoki S, Saito R, Takahashi H, Onishi H:Stereotactic Body Radiotherapy for Lymph Node Metastases. The 7th Japan-Taiwan Radiation Oncology Symposium, 2019. 5.11, Odaiba, Tokyo.
          3. Matsuda M, Oguri M, Komiyama T, Marino K, Aoki S, Maehata Y, Saito R, Akita T, Nagata N, Onishi H:Involved-field radiotherapy with concurrent chemotherapy in patients with limited-stage small-cell lung cancer. The 7th Japan-Taiwan Radiation Oncology Symposium, 2019. 5.11, Odaiba, Tokyo.
          4. Nonaka H, Onishi H, Komiyama T, Marino K, Saito R, Aoki S, Maehata Y:Pretreatment Modified Glasgow Prognostic Score as an Independent Predictor of Clinical Outcome in Patients with Stage I Non-small Lung Cancer after Stereotactic Body Radiation Therapy. The 7th Japan-Taiwan Radiation Oncology Symposium, 2019. 5.11, Odaiba, Tokyo.
          5. Saito M, Sano N, Suzuki H, Ueda K, Komiyama T, Marino K, Aoki S, Maehata Y, Saito R, Onishi H:Deep inspiration breath-hold irradiation for left side breast cancer using a new combination of respiration monitoring device andoptical body surface monitoring system. The 7th Japan-Taiwan Radiation Oncology Symposium, 2019. 5.11, Odaiba, Tokyo.
          6. Vu Hong N, Saito M, Sano N, Onishi H:Assessment of the intra-fractional tumor motion during stereotactic body radiotherapy period in patients with stage I non-small cell lung cancer: Could the tumor changes in location over an SBRT course relate to the prognosis? The 7th Japan-Taiwan Radiation Oncology Symposium, 2019. 5.11, Odaiba, Tokyo.
          7. Ichikawa S, Motosugi U, Takashi Kakegawa1 HK, and Hiroshi Onishi1, Kromrey ML, Tamada D, Wakayama T, Wang K, Cashen T, Ersoz A, Onishi H:Breath hold free hepatobiliary phase imaging: usefulness of stack-of-stars acquisition. ISMRM 27th Annual Meeting & Exhibition, 2019. 5.11-16, Montreal, Canada.
          8. Tamada D, Onishi H, Motosugi U:Mapping T1, T2, and proton density fat fraction of the liver using MR Fingerprinting with three-point DIXON and 6-peak fat model. ISMRM 27th Annual Meeting & Exhibition, 2019. 5.11-16, Montreal, Canada.
          9. Kawamura M, Tamada D, Funayama S, Onishi H, Motosugi U:Noise2Noise MRI for High-resolution Diffusion-weighted Imaging of the Brain: Deep Learning-based denoising without need for Highly Averaged Ground-truth Images. ISMRM 27th Annual Meeting & Exhibition, 2019. 5.11-16, Montreal, Canada.

           

          2018年

          招聘講演

          1. Onishi:Updates in SBRT. The Lung Preceptorship Program by Lung Cancer Consortium Singapore (LCCS), 2018. 3.26, Academia, Singapore.
          2. Onishi:Immuno-RT in Lung Cancerect. The Lung Preceptorship Program by Lung Cancer Consortium Singapore (LCCS), 2018. 3.26, Academia, Singapore.
          3. Motosugi U:Japanese Society of Hepatology Consensus/Evidence-based Guideline.The 6th International Congress on Magnetic Resonance Imaging (ICMRI 2018) and 23rd Scientific Meeting of KSMRM, 2018. 3.29-31, Seoul, Korea.
          4. Motosugi U:Body MRI Update: Clinical Applications of SIGNA Works in Abdominal Imaging. The 6th International Congress on Magnetic Resonance Imaging (ICMRI 2018) and 23rd Scientific Meeting of KSMRM, 2018. 3.29-31, Seoul, Korea.
          5. Onishi H:SBRT for oligometastases on mainly lung. 2018 Trilateral Symposium by Radiation Oncology Societies in China, Japan and Korea by The Korean Society for Radiation Oncology (KOSRO) , 2018. 5.12, Jeju Island, Korea.
          6. Onishi H:Immuno-radiotherapy: inseparable encounter like Sashimi and Wasabi. The 6th Taiwan-Japan Radiation Oncology Symposium, 2018. 5.19, Taichung, Taiwan.
          7. Motosugi U:Challenges in Diagnosing Hepatocellular Carcinoma (HCC) – valuable tips on using Primovist. 3rd Asia Pacific Liver Imaging Symposium (APLIS) 2018, 2018. 10.19-20, Shanghai, China.
          8. Onishi H:Current status and future of radiation therapy: developing to be a main stream of cancer treatment. Lecture at ALSA University of Sultan Zainal Abidin (UniSZA), 2018. 11.22, Kuala Terengganu, Malaysia.
          9. Onishi H:Radiotherapy for oligometases, mainly in lung. アジア肺癌学会, 2018. 11.30, Taipei, Taiwan.
          10. Onishi H:Individual difference of post irradiated antitumor effect and lung damage in patients with lung cancer. ICRP-QST-RERF Workshop on Individual Response to Ionising Radiation (Current Scientific Evidence on Factors that Influence Individual Response), 2018. 12.12, National Cancer Center Japan, Research Institute, Tokyo.
          11. Motosug U:Liver MRI and HCC. Resident lecture at University of Toronto, 2018. 12. 3, Toronto, Canada.
          12. Motosug U:Incidentally detected pancreas tumors: characteristic findings for differential diagnosis. Resident lecture at University of Toronto, 2018. 12. 3, Toronto, Canada.
          13. Motosug U:Technical advances in liver MRI. Resident lecture at University of Toronto, 2018. 12. 3, Toronto, Canada.
          14. Araki T:Techniques, material and results in embolization for upper GI bleeding. The 3rd GEST Asia 2018 (The Global Embolization Symposium and Technologies), 2018. 12. 7- 8, Hong Kong.
          15. Araki T:BRTO: Review of venous anatomy and variants. The 3rd GEST Asia 2018 (The Global Embolization Symposium and Technologies), 2018. 12. 7- 8, Hong Kong.

          発表

          1. Ichikawa S, Motosugi U, Onishi H:Differentiation of inflammatory pseudo-tumour from colorectal liver metastases on gadoxetic acid-enhanced magnetic resonance imaging. European Congress of Radiology (ECR) 2018, 2018. 2.28- 3.4, Vienna, Austria.
          2. Motosugi U, Ichikawa S, Onishi H:How to avoid gadoxetic acid-related artefacts? Prospective multi-institutional study in 1994 patients. European Congress of Radiology (ECR) 2018, 2018. 2.28- 3.4, Vienna, Austria.
          3. Tamada D:Motion Artifact Reduction in Abdominal MR Imaging using the U-NET Network. The 6th International Congress on Magnetic Resonance Imaging (ICMRI 2018) and 23rd Scientific Meeting of KSMRM, 2018. 3.29-31, Seoul, Korea.
          4. Tamada D:Development of mathematical phantoms for MRI simulators. The 6th International Congress on Magnetic Resonance Imaging (ICMRI 2018) and 23rd Scientific Meeting of KSMRM, 2018. 3.29-31, Seoul, Korea.
          5. Tamada D, Wakayama T, Motosugi U, Onishi H:Simultaneous mapping of R2*, T1, and proton density fat fraction for the liver: single breath-hold acquisition with multi-echo spoiled gradient echo and compressed sensing. Joint Annual Meeting ISMRM-ESMRMB 2018, 2018. 6.16-21, Paris, France.
          6. Tamada D, Motosugi U, Onishi H:Improving the image quality of liver DWI using the convolutional neural network-based selection algorithm. Joint Annual Meeting ISMRM-ESMRMB 2018, 2018. 6.16-21, Paris, France.
          7. Shimizu T, Motosugi U, Funayama S, Mitsui T, Takeda M, Onishi H:Measurement using 3D-FSE-T2WI is useful in predicting early recovery of continence following radical prostatectomy in patients with prostate carcinoma. Joint Annual Meeting ISMRM-ESMRMB 2018, 2018. 6.16-21, Paris, France.
          8. Sasaki Y, Motosugi U, Takamura T, Kevin G, Ehman R, Kumagai H, Kakegawa T, Onishi H:Regional Changes in Brain Stiffness with Age Assessed with MR Elastography. Joint Annual Meeting ISMRM-ESMRMB 2018, 2018. 6.16-21, Paris, France.
          9. Ichikawa S, Motosugi U, Omiya Y, Onishi H:Linear contrast agent-induced high signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images in pediatric patients. Joint Annual Meeting ISMRM-ESMRMB 2018, 2018. 6.16-21, Paris, France.
          10. Satoh Y, Imai M, Ikegawa C, Arai T:Dedicated breast PET versus whole-body PET/CT: a comparative study. SNMMI Annual Meeting, 2018. 6.22-26, Philadelphia, USA.
          11. Satoh Y, Motosugi U, Omiya Y, Onishi H:Diagnostic performance of dedicated breast positron emission tomography in cases of histology-unknown abnormal uptake, and parameters associated with breast cancer. SNMMI Annual Meeting, 2018. 6.22-26, Philadelphia, USA.
          12. Araki T, Okada H, Imaizumi A, Onishi H:Angiographic anatomy of the left inferior phrenic vein and left adrenal vein in patients with normal liver – anastomoses with portal venous system. Annual Meeting and Postgraduate Course of the Crdiovascular and Interventional Radiological Society of Europe (CIRSE 2018), 2018. 9.22-25, Lisbon, Portugal.
          13. Chen Z, Nonaka H, Akita T, Marino K, Aoki S, Komiyama T, Kuriyama K, Onishi H:A novel risk assessment method using pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte rates for early-stage non-small-cell lung cancer treated with stereotactic body radiation therapy. ASTRO’s 60th Annual Meeting, 2018. 10.21-24, Texas, USA.
          14. Onishi H, Imai T, Ito M, Matsumoto Y, Onimaru R, Shioyama Y, Yoshitake T, Kokubo M, Takayama K, Yamashita H, Matusuo Y, Matsushita H, Karasawa K, Kuriyama K, Komiyama T, Shirato H:Single nucleotide polymorphisms of inflammation-related genes as predictive risk factors of radiation pneumonitis after stereotactic body radiation therapy for stage I non-small cell lung cancer. ASTRO’s 60th Annual Meeting, 2018. 10.21-24, Texas, USA.
          15. Vu Hong N, Saito M, Sano N, Kuriyama K, Komiyama T, Marino K, Aoki S, Onishi H:Shrinkage of tumor volume during stereotactic body radiotherapy related to better prognosis in patients with stage Ⅰnon-small-cell lung cancer. ASTRO’s 60th Annual Meeting, 2018. 10.21-24, Texas, USA.
          16. Funayama S, Motosugi U, Wakana S, Nonaka H, Watanabe H, Onishi H:The Radiomics Prognostic Score (RadScore): The New Prognostic Imaging Biomarker After Stereotactic Body Radiation Therapy in Patients with Lung Cancer. The 104th Scientific Assembly and Annual Meeting (RSNA 2018), 2018. 11.25-30, Chicago, USA.
          17. Kobayashi H, Motosugi U, Ichikawa S, Enomoto N, Inoue T, Onishi H:MRI-based Monitoring of the Patients with Hepatitis C, Who Achieved Sustained Virological Response (SVR) by DAA Treatment. The 104th Scientific Assembly and Annual Meeting (RSNA 2018), 2018. 11.25-30, Chicago, USA.
          18. Ichikawa S, Motosugi U, Onishi H:Emergency Cases Resulting from Fish Bone Ingestion. The 104th Scientific Assembly and Annual Meeting (RSNA 2018), 2018. 11.25-30, Chicago, USA.

           

          2017年

          招聘講演

          1. Ichikawa S:MR-Guided Focused Ultrasound (FUS) for Uterine Fibroids in Japan. Imaging in Hawaii, 2017. 3.21-24, Hawaii, USA.
          2. Ichikawa S:Diagnostic Imaging of Solid Lesions of the Pancreas (Except for Invasive Ductal Carcinoma). Imaging in Hawaii, 2017. 3.21-24, Hawaii, USA.
          3. Ichikawa S:MRI Interpretation of Liver Nodules in Cirrhosis Using LI-RADS. Imaging in Hawaii, 2017. 3.21-24, Hawaii, USA.
          4. Motosugi U:MRI in the Cirrhotic liver. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
          5. Araki T:Changes of extrahepatic hemodynamics in portal hypertension – Portosystemic venous shunt -. Update on interventional and diagnostic Radiology seminar, 2017. 3.27-28, Ho Chi Minh, Viet Nam.
          6. Motosugi U:MRI in the Cirrhotic liver. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
          7. Onishi H:Interpretation and management of oligometastases. ESTRO 36th Annual Congress 2017 (European Society for Radiotherapy and Oncology), 2017. 5.5- 9, Vienna, Austria.
          8. Onishi H:Pain and gain of stereotactic body radiation therapy (SBRT). The 5th Japan-Taiwan Radiation Oncology Symposium, 2017. 5.20, Kobe.
          9. Motosugi U:Gadoxetic acid-induced transient dyspnea and transient severe motion. KSMRM-JSMRM Joint Symposium 2 (第45回 日本磁気共鳴医学会大会) 2017. 9.14-16, Utsunomiya.
          10. Onishi H:Possibility of Radiotherapy for GGO-Containing Tumors. 18th World Conference on Lung Cancer ( WCLC 2017), 2017. 10.15-18, Yokohama, Japan.

           

          発表

          1. Omiya Y, Motosugi U, Ichikawa S, Umeda T, Onishi H:Utility of uptake rate in the thyroid bed measured by 123I tracer study before 131I radioactive iodine therapy for papillary thyrold cartinoma to predict treatment outcome. European Congress of Radiology (ECR) 2017, 2017. 3.1-5, Vienna, Austria.
          2. Ichikawa S, Motosugi U, Oguri M, Onishi H:Magnetic resonance elastography for prediction of radiation-induced liver disease after stereotactic body radiation therapy. European Congress of Radiology (ECR) 2017, 2017. 3.1-5, Vienna, Austria.
          3. Funayama S, Motosugi U, Ichikawa S, Onishi H:Diagnosis of Liver Cirrhosis Using Morphological Score with Magnetic Resonance Laparoscopy. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
          4. Matsuda M, Ichikawa S, Motosugi U, Matsuda M, Onishi H:Gadoxetic acid-enhanced MRI findings as a risk of multicentric recurrence of hepatocellular carcinoma after hepatectomy. ISMRM 25th Annual Meeting & Exhibition 2017. 4.22-27, Hawaii, USA.
          5. Mori Y, Motosugi U, Shimizu T, Ichikawa S, Onishi H:Bayesian prediction for insufficient liver enhancement in gadoxetic acid-enhanced hepatobiliary phase imaging. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
          6. Ichikawa S, Motosugi U, Omiya Y, Onishi H:Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
          7. Omiya Y, Ichikawa S, Motosugi U, Onishi H:Magnetic resonance elastography for uterine fibroids. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
          8. Takamura T, Ueda R, Hori M, Irie R, Kamagata K, Suzuki M, Aoki S:The Utility of DTI and NODDI for Assessment of Disease Severity and in Predicting Postoperative Neuronal Recovery: An Atlas-based Tract Specific Study. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA. (『summa cum laude』受賞)
          9. Le Bihan D, Ichikawa S, Motosugi U:IVIM virtual MR elastography of the liver. ISMRM 25th Annual Meeting & Exhibition, 2017. 4.22-27, Hawaii, USA.
          10. Komiyama T: The results of escalated stereotactic body radiation therapy for stage ⅠA non-small cell lung cancer. The 5th Japan-Taiwan Radiation Oncology Symposium, 2017. 5.20, Kobe.
          11. Matasuda M: Stereotactic body radiation therapy using CyberKnife for patients with hepatocellular carcinoma. The 5th Japan-Taiwan Radiation Oncology Symposium, 2017. 5.20, Kobe.
          12. Satoh Y, Motosugi U, Saito A, Omiya Y, Onishi H:Pretreatment FDG Uptake in the Lung Parenchyma Predicts Poor Survival after Stereotactic Body Radiation Therapy for Stage I Non-small Cell Lung Cancer. The SNMMI Annual Meeting, 2017. 6.12, Denver, Colorado, USA.
          13. Ichikawa S, Motosugi U, Oishi N, Wakayama T, Onishi H:Pathological feature of hepatocellular carcinomas showed ring-like enhancement on all phases of multiphasic dynamic magnetic resonance imaging. ESGAR (European Society of Gastrointestinal and Abdominal Radiology) 2017 (28th Annual Meeting), 2017. 6.20-23, Athens, Greece.
          14. Saito M, Shibata Y, Sano N, Kuriyama K, Komiyama T, Marino K, Aoki S, Ashizawa K, Yoshizawa K, Onishi H:Evaluation of the Accurancy of Deformable Image Registration Between KVCT and MVCT Combined with a Histogram Matching Algorithm. AAPM 2017 59th Annual Meeting & Exhibition (The American Association of Physicists in Medicine), 2017. 7.30-8.3, Denver, USA.
          15. Tamada D, Motosugi U, Onishi H:Three-dimensional compressed sensing using two orthogonal readout gradients. 14th ICMRM 2017 (International Conference on Magnetic Resonance Microscopy), 2017. 8.13-17, Halifax, Nova Scotia, Canada.
          16. Araki T, Imaizumi A, Okada H, Onishi H:Unusual anatomical variants of the left adrenal vein via the renal capsular vein for adrenal vein sampling. CIRSE 2017 (Cardiovascular and Interventional Radiological Society of Europe), 2017. 9.16-20, Copenhagen, Denmark.
          17. Nonaka H, Onishi H, Watanabe M, Nam V:Assessment of abdominal organ motions using cine-MRI in different gastroduodenal peristaltic motilities: a comparison between empty and full stomach. American Society for Radiation Oncology 59th Annual Meeting (ASTRO), 2017. 9.24-27, San Diego, USA.
          18. Onishi H, Nagata Y, Hiraoka M, Wakabayashi M, Eba J, Ishikura S, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa K, Hareyama M, Takai Y, Hayakawa K, Mitsuhashi N:Radiation pneumonitis and change of pulmonary function after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer and their impact on survival in a supplementary analysis of Japan Clinical Oncology Group (JCOG) study JCOG0403. American Society for Radiation Oncology 59th Annual Meeting (ASTRO), 2017. 9.24-27, San Diego, USA.
          19. Komiyama T:〔Discussant〕. 18th World Conference on Lung Cancer ( WCLC 2017), 2017. 10.15-18, Yokohama, Japan.
          20. Ichikawa S, Motosugi U, Onishi H:Acute Abdomen Due to Meckel Diverticulum. The 103rd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2017. 11.26-12. 1, Chicago, USA.
          21. Funayama S, Ichikawa S, Motosugi U, Matsuda M, Katoh R, Onishi H:Comparison of Diagnostic Performances of Magnetic Resonance Elastography and Serum Markers for Liver Fibrosis Staging. The 103rd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2017. 11.26-12. 1, Chicago, USA.

           

          2016年

          招聘講演

          1. Ichikawa S:Recent Updates of DWI including Non-monoexponential Methods. The 4th International Congress on MRI & 21th Annual Scientific Meeting of KSMRM, 2016. 3.25-26, Seoul, Korea.
          2. Motosugi U:MR elastography-Principle. The 4th International Congress on MRI & 21th Annual Scientific Meeting of KSMRM, 2016. 3.25-26, Seoul, Korea.
          3. Motosugi U:Liver MRI update. The 4th International Congress on MRI & 21th Annual Scientific Meeting of KSMRM, 2016. 3.25-26, Seoul, Korea.
          4. Motosugi U:MRI Charaterization of Lesions in the Cirrhotic Liver. ISMRM 24th Annual Meeting & Exhibition 2016. 5.7-13, Singapore.
          5. Onishi H:SBRT for Stage 1 NSCLC. 3rd International SBRT Symposium & Workshop, 2016. 6.21-25, Singapore.
          6. Onishi H:SBRT for various organs and its toxicity. 3rd International SBRT Symposium & Workshop, 2016. 6.21-25, Singapore.
          7. Motosugi U:Imaging for selection and prioritization of LT candidates with HCC: the Asian Perspective. The 16th Asian Oceanian Congress of Radiology (AOCR 2016), 2016. 8.18-21, Beijing, China.
          8. Ichikawa S:Quantitative MR imaging for diffusse liver disease. The 72nd Korean Congress of Radiology (KCR 2016), 2016. 9.21-23, Seoul, Korea.
          9. Motosugi U:Imaging for Selection and Prioritization of LT Candidates with HCC: The Asian Perspective. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
          10. Motosugi U:Hypovascular and Hypointense Nodule in Gadoxetic Acid-Enhanced Liver MRI: Outcome and Management. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
          11. Onishi H:SBRT for primary or oligometastatic lung cancer: current status and the future. 2016 Advanced Radiation Therapy Summit : Tiwan-Japan (ARTS-2016), 2016. 12.10, Taipei, Taiwan.

          発表

          1. Ichikawa S:Magnetic resonance elastography as a predictor of response to treatment of magnetic resonance-guided focused ultrasound for uterine fibroids: a preliminary study, European Congress of Radiology (ECR) 2016, 2016. 3.2-6, Vienna, Austria.
          2. Ichikawa S, Motosugi U, Morisaka H, Enomoto N, Matsuda M, Fujii H, Onishi H:Intravoxel incoherent motion diffusion-weighted imaging is a better indicator of high grade hepatocellular carcinoma than conventional apparent diffusion coefficient. The 7th Asian-Pacific Topic Conference (APTC2016), 2016. 4.20, Tokyo. 
          3. Ichikawa S, Motosugi U, Wakayama T, Kakegawa T, Kumagai H, Onishi H:Improved detection of capsular enhancement in hepatocellular carcinoma using multiphasic hepatic arterial imaging and DIfferential Sub-sampling with Cartesian Ordering (DISCO) in gadoxetic acid-enhanced magnetic resonance imaging. ISMRM 24th Annual Meeting & Exhibition, 2016. 5.7-13, Singapore.
          4. Takamura T, Murata S, Kamagata K, Tsuruta K, Hori M, Suzuki M, Aoki S:Extensive White Matter Damage in Neuromyelitis Optica Assessed by Neurite Orientation Dispersion and Density Imaging: A Tact-Based Spatial Statistics study. ISMRM 24th Annual Meeting & Exhibition 2016. 5.7-13, Singapore.
          5. Funayama S, Marino K, Nonaka H, Aoki S, Komiyama T, Kuriyama K, Onishi H:Stereotactic Body Radiation Therapy for Primary Lesion of Renal Cell Carcinoma. The 4th Taiwan-Japan Radiation Oncology Symposium, 2016. 6. 4, Taipei, Taiwan.
          6. Matsuda M, Onishi H, Komiyama T, Kuriyama K, Satani K, Takahashi H:Stereotactic Body Radiation Therapy for Lymph Node Metastases. The 4th Taiwan-Japan Radiation Oncology Symposium, 2016. 6. 4, Taipei, Taiwan.
          7. Motosugi U, Bannas P, Bookwalter CA, Sano K, Reeder SB:Respiratory motion artifact during arterial phase imaging with gadoxetic acid: a study at 2 sites in dirrerent continents. ESGAR 2016 (European Society of Gastrointestinal and Abdominal Radiology), 2016. 6.14-17, Prague, Czech Republic.
          8. Ichikawa S, Motosugi U, Hernando D, Morisaka H, Onishi H:Comparing the results of intravoxel incoherent motion diffusion-weighted imaging calculated by different estimation methods: discrimination of histological grade of HCC. ESGAR 2016 (European Society of Gastrointestinal and Abdominal Radiology), 2016. 6.14-17, Prague, Czech Republic.
          9. Onishi H, Shioyama Y, Matsumoto Y, Takayama K, Matsuo Y, Miyakawa A, Yamashita H, Matsushita H, Aoki M, Nihei K, Kimura T, Ishiyama H, Murakami N, Nomiya T, Uno T, Takanaka T, Takeda A, Kato N, Nakata K, Ogawa K:Excellent survival!-multi-institutional study of stereotactic body radiotherapy for medically operable and young (70 years old or younger) patients with stage I non-small cell lung cancer. American Society for Radiation Oncology 58th Annual Meeting (ASTRO), 2016. 9.25-28, Boston, USA.
          10. Ichikawa S, Motosugi U, wakayama T, Onishi H:Risk Assessment for Hepatocellular Carcinoma by Using Magnetic Resonance Elastography during Follow-up. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
          11. Shimizu T, Motosugi U, Ichikawa S, Onishi H:Assessing the Risk of Developing Hepatocellular Carcinoma by Gadoxetic Acid-enhanced MRI and MR Elastography: A Prospective Study. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
          12. Shimizu T, Motosugi U, Sano K, Ichikawa S, Onishi H:Long-term Observation of Hypovascular Hypointense Nodules (HHNs) on Gadoxetic Acid-enhanced MRI. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
          13. Omiya Y, Ichikawa S, Motosugi U, Onishi H:Preoperative Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Predicts Better Prognosis after Surgical Resection in Patients with Pancreatic Cancer. The 102nd Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2016. 11.27-12.2, Chicago, USA.
          14. Onishi H, Shioyama Y, Matsumoto K, Takayama K, Matsuo Y, Miyakawa A, Yamashita H, Matsushita H, Aoki M, Nihei K:Excellent Survival Achieved by Stereotactic Body Radiotherapy for Medically Operable and Young (< 75 Years) Patients with Stage I Lung Cancer. 17th IASLC World Conference on Lung Cancer, 2016. 12.4-7, Vienna, Austria.
          15. Komiyama T, Kuriyama K, Marino K, Aoki S, Araya M, Onishi H:Primary Results of Dose Escalated Stereotactic Body Radiotherapy for Stage IA Non-Small Cell Lung Cancer. 17th IASLC World Conference on Lung Cancer, 2016. 12. 4- 7, Vienna, Austria.

           

          2015年

          招聘講演

          1. Ichikawa S:Clinical Application of EOB (Eovist)-enhanced MR. IMAGING IN HAWAII, 2015. 3.23-26, Hawaii, USA.
          2. Ichikawa S:CT and MR Protocols for Pancreatic Tumors. IMAGING IN HAWAII, 2015. 3.23-26, Hawaii, USA.
          3. Onishi H:Lung SBRT in the next 10 years; lessons learnt from the JCOG 0403. Radiology Asia 2015, 2015. 5.14-16, Singapore.
          4. Onishi H:Dose escalation in unresectable Stage 3 NSCLC. Where do we go from here. Radiology Asia 2015, 2015. 5.14-16, Singapore.
          5. Onishi H:Pneumonitis in lung radiotherapy: Prevention and Diagnosis. Radiology Asia 2015, 2015. 5.14-16, Singapore.
          6. Onishi H:Lung Oligometastases: Results of SBRT. Radiology Asia 2015, 2015. 5.14-16, Singapore.
          7. Onishi H:A New Horizon of Radiotherapy Expanded by Hypofractionated Irradiation. ICRR 2015 (15th International Congress of Radiation Research) 2015. 5.25-29, Kyoto.
          8. Motosugi U:Update on Contrast Agents for Body Imaging: Hepatobiliary Contrast Agents. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.
          9. Onishi H:Important Points of Treatment-related Toxicity caused by Stereotactic Body Radiation Therapy. ISRS 2015 (12th International Stereotactic Radiosurgery Society Congress), 2015. 6.7-11, Yokohama.
          10. Onishi H:For the Future: Expanding Role of SBRT for Not Only Medically Inoperable or High-risk Operable But Also Low-risk Operable Patients. The 3rd Japan-Taiwan Radiation Oncology Symposium, 2015. 6.27, Fujiyosida. (Organizer Speech)
          11. Onishi H:Expanding Role of Stereotactic Body Radiotherapy and The Importance of Respiration Motion Control. Lecture of Prof. Onishi “Stereotactic Body Radiotherapy”, 2015. 8.14, Taipei Veterans General Hospital (台北栄民総病院).
          12. Onishi H:Expanding Role of Stereotactic Body Radiotherapy and The Importance of Respiration Motion Control. Lecture of Prof. Onishi “Stereotactic Body Radiotherapy”, 2015. 8.14, Shin Kong Wu Ho-Su Memorial Hospital (新光呉火獅記念病院).
          13. Onishi H:Clinical efficiency of stereotactic ablative radiotherapy for lung cancer. The 2015 Symposium on the Latest Advances of Radiation Oncology, Chenzhou, 2015. 9. 5- 6, Hunan, Chaina.

          発表

          1. Onishi H, Shioyama Y, Matsumoto Y, Takayama K, Matsuo Y, Miyakawa A, Yamashita H, Matsushita H, Aoki M, Nihei K, Nomiya T, Katoh N, Nakata K, Uno T, Murakami N:Japanese Multi-institutional Study of SBRT for More than 2000 Patients with Stage I Non-small Cell Lung Cancer or Pulmonary Oligometastases. ICRR 2015 (15th International Congress of Radiation Research), 2015. 5.25-29, Kyoto. 〔JRR Award at ICRR 2015〕
          2. Komiyama T, Kuriyama K, Muramatsu J, Oguri M, Nonaka H, Chen Z, Sano N, Asizawa K, Onishi H:High Dose Concurrent Chemoradiotharapy for Locally Advanced, Post Operative Residual or Recurrent Non-small-cell Lung Cancer. ICRR 2015 (15th International Congress of Radiation Research), 2015. 5.25-29, Kyoto.  
          3. Oguri M, Kuriyama K, Komiyama T, Nonaka H, Chen Z, Onishi H:Helical Tomotherapy in Radiotherapy for Prostate Cancer-A Dosimetric Comparison of Static Jaw and TomoEDGE Dynamic Jaw Delivery. ICRR 2015 (15th International Congress of Radiation Research), 2015. 5.25-29, Kyoto.  
          4. Araki T, Okada H, Tominaga R, Onishi H:Therapeutic efficacy and liver function change by embolization of portosystemic venous shunt for hepatic encephalopathy without or with liver cirrhosis. 44th JSIR, ISIR & APCIO 2015, 2015. 5.28-30, Miyazaki.
          5. Araki T, Okada H, Tominaga R, Onishi H:Endovascular marking for abdominal radiotherapy using CyberKnife: second report. 44th JSIR, ISIR & APCIO 2015, 2015. 5.28-30, Miyazaki.
          6. Okada H, Araki T, Onishi H:Treatment outcome of selective arterial infusion chemotherapy with radiotherapy for bladder cancer in our hospital. 44th JSIR, ISIR & APCIO 2015, 2015. 5.28-30, Miyazaki.  
          7. Motosugi U, Bannas P, Bookwalter CA, Reeder SB:Prospective Assessment of Transient Dyspnea and Arterial Oxygen Saturation After Injection of Gadoxetetic Acid in a Large Patient Cohort. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.
          8. Motosugi U, Bannas P, Roldan-Alzate A, Kelly SG, Said A, Wieben O, Reeder SB:4D-Flow MRI for Risk Stratification of Gastroesophageal Varices in Cirrhotic Patiants. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.
          9. Motosugi U, Hernando D, Bannas P, Reeder SB:High SNR Improves the Repeatability of Proton Density Fat Fraction Measurements in the Liver. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.
          10. Motosugi U, Bannas P, Hernando D, Rahimi MS, Holmes JH, Reeder SB:Intra-Individual Crossover Comparison of Dose of Gadoxetic Acid for Liver MRI: Parameter Optimization and Quantitative Relaxometry in Normal Volunteers. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.  
          11. Morisaka H, Motosugi U, Ichikawa S, Sano K, Ichikawa T, Nakano M, Onishi H:Distinguishing Early and Progressed HCC Using Texture Analysis Using Gadoxetic Acid-Enhanced Hepatobiliary Phase Image. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6. 5, Toronto, Canada.  
          12. Takamura T, Motosugi U, Ichikawa S, Sano K, Morisaka H, Ichikawa T, Enomoto N, Onishi H:The Usefulness of Magnetic Resonance Elastography in Predicting Progression of Cirrhosis from Child-Pugh Class a to B. ISMRM 23rd Annual Meeting & Exhibition (International society for Magnetic Resonance in Medicine), 2015. 5.30- 6.5, Toronto, Canada.〔Magna Cum Laude Merit Award〕 
          13. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Onishi H:A study of validation and reliability for liver stiffness measurement with magnetic resonance elastography for staging hepatic fibrosis in patients with chronic hepatitis B. ESGAR 2015 (European Society of Gastrointestinal and Abdominal Radiology), 2015. 6.9-12, Paris, France.
          14. Komiyama T, Kuriyama K, Muramatsu J, Oguri M, Nonaka H, Chen Z, Sano N, Ashizawa K, Onishi H:Relationship Between Patterns of Failure and Cause of Death after Stereotactic Body Radiotherapy for Stage ⅠA Non-small-cell Lung Cancer. The 3rd Japan-Taiwan Radiation Oncology Symposium, 2015. 6.28, Fujiyosida.
          15. Onishi H:Japanese Multi-institutional Study of Stereotactic Body Radiation Therapy for 678 Medically Operable Patients With Stage I Non-Small Cell Lung Cancer. American Society for Radiation Oncology 57th Annual Meeting (ASTRO), 2015. 10.18-21, San Antonio, USA.
          16. Onishi H:Dose escalation study of stereotactic body radiotherapy (SBRT) for peripheral T2N0M0 non-small cell lung cancer (NSCLC) with PTV ≥ 100 cc: Japan Clinical Oncology Group Study (JCOG0702). American Society for Radiation Oncology 57th Annual Meeting (ASTRO), 2015. 10.18-21, San Antonio, USA.
          17. Shimizu T, Sano K, Ichikawa T, Motosugi U, Morisaka H, Ichikawa S, Onishi H, Matsuda M, Fujii H:Hepatocellular Carcinoma without Gadoxetic Acid Uptake on Preoperative MR Imaging: An Important Prognostic Risk Factor after Liver Resection. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
          18. Motosugi U, Yamaguchi H, Morisaka H:Solid Pseudopapillary Neoplasm of the Pancreas: Minimum Knowledge in Pathology to Understand Variation of Imaging Features. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
          19. Sano K, Ichikawa T, Shimizu T, Motosugi U, Morisaka H, Ichikawa S, Onishi H, Matsuda M, Fujii H:Presence of Hypovascular and Hypointense Nodules on Preoperative Gadoxetic Acid-enhanced MR Imaging: An Important Risk Factor for Recurrence after Liver Resection for Hypervascular Hepatocellular Carcinoma. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
          20. Sano K, Ichikawa T, Motosugi U, Morisaka H, Ichikawa S, Matsuda M, Onishi H, Fujii H:Early Hepatocellular Carcinoma: Clinical Features, Impact, and Radiologic-pathologic Correlation. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
          21. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Onishi H:Intravoxel Incoherent Motion Diffusion-weighted Imaging is a Better Indicator of High Grade Hepatocellular Carcinoma Than Conventional Apparent Diffusion Coefficient. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
          22. Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Onishi H:Noninvasive Hepatic Fibrosis Staging Using Magnetic Resonance Elastography: The Usefulness of the Bayesian Prediction Method. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
          23. Morisaka H, Ichikawa T, Kondo F, Sano K, Ichikawa S, Motosugi U, Onishi H:Combined Hepatocellular and Cholangiocarcinoma of the Liver: Minimum Knowledge of Pathology and Variation in Imaging Features. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.
          24. Nonaka H:Stereotactic Body Radiation Therapy for Primary Lesion of Renal Cell Carcinoma. The 101st Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2015. 11.29-12. 4, Chicago, USA.

          2014年

          招聘講演

          1. Onishi H:Stereotactic Body Radiotherapy for stage Ⅰ non- small cell lung cancer-Japanese status. 1st GI-CoRE Medical Science and Engineering Symposium~Hokkaido Univ. and Stanford Univ. Joint Symposium~, 2014. 2.23, Sapporo.
          2. Onishi H:Latest advances in SBRT for non-small-cell lung cancer. Asian Oncology Summit 2014, 2014. 4.11-13, Kuala Lumpur, Malaysia.
          3. Onishi H:Stereotactic Ablative Body Radiotherapy (SABR) for Various Disease Status. 11th International Conferance of the Asian Clinical Oncology Society in conjuction with the 19th Taiwan Joint Cancer Conference, 2014. 5.2-4, Taipei, Taiwan.
          4. Motosugi U:Diffusion-weighted imaging of hepatic tumors: current knowledge and update (Joint Symposium with JRS). The 70th Korean Congress of Radiology And Annual Delegate Meeting of The Korean Society of Radiology (KCR 2014), 2014. 10. 8-11, Seoul, Korea.

          発表

          1. Ichikawa S, Motosug U, Morisaka H, Sano K, Ichikawa T:Intravoxel incoherent motion diffusion-weighetd imaging for staging for hepatic fibrosis. European Congress of Radiology (ECR) 2014, 2014. 3.6-10, Vienna, Austria.
          2. Omiya Y, Motosugi U, Sano K, Morisaka H, Ichikawa S, Matsuda M, Fujii H, Ichikawa T:The relationship of vascular invasion and signal intensity of hepatocellular carcinomas on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging. European Congress of Radiology (ECR) 2014, 2014. 3.6-10, Vienna, Austria.
          3. Motosugi U, Hernando D, Bannas P, Holmes JH, Wang K, Simakawa A, Iwadate Y, Taviani V, Reeder SB:Free-Breathing Quantification of Liver Proton Density Fat-Fraction. Joint Annual Meeting ISMRM – ESMRMB, 2014. 5.10-16, Milano, Italy.
          4. Ichikawa S, Motosugi U, Shimizu T, Morisaka H, Sano K, Ichikawa T, Kakegawa T, Ikenaga S, Kumagai H, Onishi H:Magnetic Resonance Queckenstedt’s Test: A Preliminary Experience. Joint Annual Meeting ISMRM – ESMRMB, 2014. 5.10-16, Milano, Italy.
          5. Araki T:Angiographic Anatomy of the Celiac Trunk. The 4th Mongolian-Japanese Joint Radiological International Symposium – 2014, 2014. 7.4-8, Ulan Bator, Mongol.
          6. Onishi H, Matsumoto Y, Miyakawa A, Yamashita H, Nomiya T, Niibe Y, Nakata K, Kuriyama K, Komiyama T, Marino K, Aoki S, Maehata Y, Araya M, Saito R, Tominaga L, Oguri M, Watanabe I, Nonaka H, Sano N:Japanese Multi-Institutional Study of Stereotactic Boey Radiation Therapy for Totally 380 Patients With Lung Metastases. American Society for Radiation Oncology 56th Annual Meeting (ASTRO), 2014. 9.14-17, San Francisco, USA.
          7. Oguri M, Onishi H, Saitou A, Kuriyama K, Komiyama T, Tominaga L, Nonaka H, Omiya Y:The Factors which Influence Acute Exacerbation on Patients Receiving Stereotactic Body Radiation Therapy for Lung Cancers with “Interstitial Change”. American Society for Radiation Oncology 56th Annual Meeting (ASTRO), 2014. 9.14-17, San Francisco, USA.
          8. Nonaka H, Onishi H, Ozaki M, Tominaga L, Kuriyama K, Komiyama T, Oguri M:Re-stereotactic body radiotherapy (SBRT) for local recurrence of lung cancer previously treated with SBRT. American Society for Radiation Oncology 56th Annual Meeting (ASTRO), 2014. 9.14-17, San Francisco, USA.
          9. Satoh Y, Nambu A, Onishi H:Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. EANM ’14 27th Annual Congress of the European Association of Nuclear Medicine 2014. 10.18-22, Gothenburg, Sweden.
          10. Onishi H, Matsumoto Y, Miyakawa A, Yamashita H, Nomiya T, Niibe Y, Nakata K, Kuriyama K, Komiyama T, Marino K, Aoki S, Maehata Y, Araya M, Saito R, Tominaga L, Oguri M, Wtanabe I, Nonaka H, Sano N:Japanese Multi-institutional Study of Stereotactic Body Radiation Therapy for Totally 380 Patients With Lung Metastases. 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology, 2014. 10.30-11. 1, Chicago, USA.
          11. Sano K, Motosugi U, Ichikawa T, Ichikawa S, Morisaka H, Onohara K, Takamura T, Onishi H:The Outcome of Hypovascular and Hypointense Nodules on Hepatocyte-phase Gadoxetic Acid-enhanced Magnetic Resonance Imaging; When Does It become a Conventional HCC?: 5 Years’ Experience. The 100th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2014. 11.30-12. 5, Chicago, USA.

          2013年

          招聘講演

          1. Araki T:Angiographic Anatomy of the Celiac Trunk. The 3rd Mongolian-Japanese Joint Radiological International Symposium – 2013, 2013. 7.7-9, Ulan Bator, Mongol.
          2. Onishi H:SABR For Early Stage Lung Cancer And Pulmonary Oligometastases(WCLC:世界肺癌学会). IASLC 15th World Conference on Lung Cancer, 2013. 10.27-30, Sydney, Australia.

          発表

          1. Motosugi U, Takamura T, Ichikawa T, Sano K, Morisaka H, Ichikawa S, Araki T:MR elastography for predicting progression of cirrhosis. European Congress of Radiology (ECR) 2013, 2013. 3.7-11, Vienna, Austria.
          2. Ichikawa S, Motosgui U, Ichikawa T, Sano K, Morisaka H, Araki T:Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. European Congress of Radiology (ECR) 2013, 2013. 3.7-11, Vienna, Austria.
          3. Motosugi U, Wakayama T, Ichikawa T, Araki T, Kakite S, Dyvorne H:Comparing the results of intravoxel incoherent motion diffusion-weighted imaging calculated by different estimation methods. The 21st Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine (ISMRM), 2013. 4.20-26, Salt Lake City, USA.
          4. Morisaka H, Motosugi U, Ichikawa S, Sano K, Ichikawa T, Ikenaga S, Kumagai H, Araki T:Magnetic Resonance Elastography in the Liver – Comparison between spin-echo echo-planar-imaging and gradient-echo sequence – The 21st Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine (ISMRM), 2013. 4.20-26, Salt Lake City, USA.
          5. Onishi H:Stereotactic Radiotherapy for early stage lung cancer. Japan-Taiwan Conference on High Precision Radiotherapy, 2013. 8. 3, Tokyo.
          6. Onishi H, Shioyama Y, Matsumoto K, Takayama K, Matsuo Y, Miyakawa A:Japanese multi-institutional study of stereotactic body radiotherapy for more than 2000 patients with stage I non-small cell lung cancer. American Society for Radiation Oncology 55th Annual Meeting (ASTRO), 2013. 9.22-25, Atlanta, USA.
          7. Oguri M, Onishi H:Severe radiation pnemonitis after stereotactic radiotheraphy for patients with stage Ⅰ non-small cell lung cancer accompanying pulmonary fibrosisi. American Society for Radiation Oncology 55th Annual Meeting (ASTRO), 2013. 9.22-25, Atlanta, USA.
          8. Motosugi U, Sano K, Morisaka H, Ichikawa S, Ichikawa T:Simply Combine the Results of Multiple Elastographies and Serum Fibrosis Markers Using Bayesian Prediction for Noninvasive Liver Fibrosis Staging. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
          9. Sano K, Motosugi U, Morisaka H, Ichikawa S, Ichikawa T:Clinical Features of Hepatocellular Carcinoma Showing lsointense or Hyperintense on Hepatocyte-phase of Gadoxetic Acid-enhanced Magnetic Resonance Imaging; Radiologic-pathologic Correlation in Surgically Resected Cases. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
          10. Morisaka H, Motosugi U, Ichikawa S, Sano K, Satoshi I, Nakazawa T, Ichikawa T:Liver Fibrosis Staging: Magnetic Resonance Elastography Is Better than Liver Biopsy. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
          11. Ichikawa S, Motosugi U, Sano K, Morisaka H, Ichikawa T:Noninvasive Assessment of Hepatic Fibrosis by Liver Stiffness Measurement: Comparison of MR Elastography and Ultrasound Transient Elastography. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
          12. Ichikawa S, Motosugi U, Imaizumi M, Sano K, Morisaka H, Ichikawa T:CT Venography with Dual Energy CT: Dose Reduction of Contrast Material with Low Tube Voltage. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.
          13. Takamura T, Ichikawa S, Motosugi U, Sano K, Morisaka H, Ichikawa T:The Activity Grade of Hepatitis Affects Liver Stiffness Measured Using MR Elastography. The 99th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2013. 12.1-6, Chicago, USA.

          2012年

          招聘講演

          1. Motosugi U:MR Elastography of the Liver. The 17th Annual Scientific Meeting of Korean Society of Magnetic Resonance in Medicine, KSMRM-JSMRM joint symposium, 2012. 3.31-4.1, Incheon, Korea.

          発表

            1. Sano K, Motosugi U, Morisaka H, Sou H, Ichikawa T, Araki T:Multi-organ perfusion CT in the abdomen using a 320-detector row scanner: Preliminary results of perfusion changes in the liver, spleen, and pancreas of cirrhotic patients. European Congress of Radiology (ECR) 2012, 2012. 3.1-5, Vienna, Austria.
            2. Motosugi U, Ichikawa T, Koshiishi T, Sano K, Muhi A, Morisaka H, Araki T:Liver Stiffness Determined by MR Elastography as a Biomarker for Predicting HCC Development in Patients with Chronic Liver Disease: preliminary case-control study. European Congress of Radiology (ECR) 2012, 2012. 3.1-5, Vienna, Austria.
            3. Ichikawa S, Motosugi U, Ichikawa T, Watanabe I, Morisaka H, Sano K, Araki T:Intravoxel incoherent motion imaging of the liver: Which affects more on apparent diffusion coefficient changes of cirrhosis and liver lesions, D or D*? The 20th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine (ISMRM), 2012. 5.5-11, Melbourne, Australia.
            4. Venkatesh SK, Motosugi U, Wang G, Ichikawa T, Araki T, Lim SG, Wee A:Magnetic Resonance Elastography of Liver for Evaluation of Liver Fibrosis in Chronic Viral Hepatitis B and C in Asians: A Two Centre’s Experience. The 20th Scientific Meeting and Exhibition of International Society for Magnetic Resonance in Medicine (ISMRM), 2012. 5.5-11, Melbourne, Australia.
            5. Araki T, Okada H, Sakamoto H, Motosugi U, Araki T:Abdominal press method for the right adrenal venous movement by breathing in adrenal venous sampling. APCCVIR 2012 JSIR & ISIR, 2012. 5.30-6.2, Kobe.
            6. Araki T, Okada H, Motosugi U, Araki T:Angiographic anatomy of the left inferior phrenic vein in patients with normal liver -For balloon-occluded retrograde transvenous obliteration-. APCCVIR 2012 JSIR & ISIR, 2012. 5.30-6.2, Kobe.
            7. Okada H, Araki T, Araki T:NBCA embolization under blood-flow control with temporary balloon occlusion. APCCVIR 2012 JSIR & ISIR, 2012. 5.30-6.2, Kobe.
            8. Onishi H:Stereotactic Body Radiotherapy in 95 Patients With Lung Tumors Composed of Ground-glass Opacity (GGO) : Results of a Retrospective Multicenter study. American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
            9. Maehata Y, Onishi H, Kuriyama K, Tominaga L, Watanabe I, Oguri M, Araki T:What is the Cause of Immune Suppression in Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer? American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
            10. Oguri M, Onishi H, Nambu A, Kuriyama K, Maehata Y, Tominaga L, Araki T:Rib Fractures after Stereotactic Body Radiation Therapy for Primary Non-Small Cell Lung Cancer. American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
            11. Shibamoto Y, Sumi M, Onodera S, Matsushita H, Sugie C, Tamaki Y, Onishi H, Abe E, Koizumi M, Miyawaki D:Primary Central Nervous System Lymphoma (PCNSL) treated by radiation therapy: a nationwide survey of 2005-2009 patients and comparison with 1985-2004 data. American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
            12. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kunieda E, Ishikura S:Stereotactic body radiation therapy for T1NOMO non-small cell lung cancer:first report for inoperable population of a phase trial by Jaran Clinical Oncology Group (JCOG 0403). American Society for Radiation Oncology 54th Annual Meeting (ASTRO), 2012. 10.28-31, Boston, USA.
            13. Motosugi U, Ichikawa T, Okada M, Kondo H, Sou H, Murakami T, Kanematsu M, Hatcho A, Yoshikawa S, Awai K, Yoshimitsu K, Yamashita Y:Recommended Iodine Dose for Hepatic Arterial-dominant Phase CT Images of the Liver for Visualizing Hypervascular Hepatocellular Carcinoma (HCC): Multicenter Prospective Study in 91 Community Hospitals in Japan. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.
            14. Sano K, Motosugi U, Ichikawa T, Morisaka H, Ichikawa S, Araki T:The Outcome of Hypovascular Nodules Showing Hyperintense on Hepatocyte-Phase of Gadoxetic Acid-enhanced Magnetic Resonance Imaging: When Does It Become a Conventional HCC? 4 Years Follow-up Study. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.
            15. Ichikawa S, Motosugi U, Ichikawa T, Morisaka H, Sano K, Araki T:Was This HCC Able to Be Seen on Previous Gadoxetic Acid-enhanced MR Images? A Retrospective Review of Previous MR Images in Patients with Hypervascular HCC. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.
            16. Morisaka H, Motosugi U, Ichikawa T, Sano K, Ichikawa S, Araki T:Functional Abdominal MR Imaging for Prediction of Gastro-Esophageal Varices in Chronic Liver Disease Patients: Comparison with Liver and Spleen MR Elastography and Portal Vein Phase-Contrast MR Flow Measurements. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.
            17. Takamura T, Ichikawa S, Motosugi U, Ichikawa T, Morisaka H, Sano K, Araki T:Use of MR Elastography of the Liver for Evaluating Hepatic Fabrosis in Hepatitis C Patients. The 98th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2012. 11.25-30, Chicago, USA.

          2011年

          招聘講演

          1. Motosugi U:Multiparametric evalution of Abdominal MRI. Korean Society of Abdominal Radiology-GE Healthcare Grand Symposium(Session), 2011. 1, Seoul, Korea.
          2. Ichikawa T:Differentiation of Early HCC from DN by EOB-MRI: Japanese Perspective. The 2nd Asia- Pacific Primary Liver Cancer Expert Meeting, 2011. 7.1-3, Osaka.

          発表

          1. Motosugi U, Ichikawa T, Sou H, Sano K, Muhi A, Araki T:Effects of gadoxetic acid on liver stiffness measurement by using magnetic resonance elastography. European Congress of Radiology (ECR) 2011, 2011. 3.3-7, Vienna, Austria.
          2. Morisaka H, Motosugi U, Ichikawa T, Sou H, Araki T:Gadoxetic acid-enhanced magnetic resonance imaging for evaluation of pancreatic adenocarcinoma and liver metastasis. European Congress of Radiology (ECR) 2011, 2011. 3.3-7, Vienna, Austria.
          3. Motosugi U, Ichikawa T, Sou H, Muhi A, Amemiya F, Enomoto N, Araki T:Cross-validation of MR elastography and ultrasound transient elastography in liver stiffness measurement. European Society of Gastrointestinal and Abdominal Radiology (ESGAR) 2011, 2011. 5.21-24, Venice, Italy.
          4. Onishi H, Sato Y, Nambu A:Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy. American Society for Radiation Oncology 53rd Annual Meeting (ASTRO), 2011. 10.2-6, Miami, USA.
          5. Maehata Y, Onishi H, Kuriyama K, Aoki S, Araya M, Saito R, Oguri M, Araki T:Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer Causes Immune Suppression. American Society for Radiation Oncology 53rd Annual Meeting (ASTRO), 2011. 10.2-6, Miami, USA.
          6. Nambu A, Zach J, Lynch DA, Schroeder JD, Jin G, Schnell C, et al:Correlation between Diffusion Capacity for Carbon Monoxide (DLCO) and Quantitative CT in Smokers in a Single Institution Study. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
          7. Araki T, Okada H, Araki T:Enhancement of Ascites during Abdominal Vascular Interventions with CT-IVR Combination System. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
          8. Motosugi U, Muhi A, Ichikawa T, Sano K, Morisaka H, Sou H, Araki T:MR Elastograpy Can Predict an Insufficient Liver Enhancement on Gadoxetic Acid-enhanced Hepatocyte-Phase MR Imaging in Patients with Child-Pugh Class A Disease. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
          9. Motosugi U, Ichikawa T, Yamaguchi H, Shimizu M, Furukawa T, Araki T:Imaging Studies of Intraductal Tubulopapillary Neoplasms of the Pancreas: A Newly Categorized Pancreas Tumor by WHO Classification. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
          10. Sano K, Ichikawa T, Motosugi U, Morisaka H, Sou H, Muhi A, Araki T:Visual Analog Scale (VAS) Evalution of Diagnostic Confidence and Fatigue Degree: Influence of Iodine Dose for Adominal Contrast-enhanced MDCT in the Daily Work. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
          11. Ichikawa S, Motosugi U, Ichikawa T, Sano K, Sou H, Muhi A, Araki T:Intravoxel Incoherent Motion Diffusion-weighted Imaging for Distinguishing between Malignant and Benign Hepatic Focal Liver Lesions. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
          12. Muhi A, Sano K, Motosugi U, Ichikawa T, Morisaka H, Onohara K, Araki T:The Outcome of Hypovascular and Hypointense Nodules on Hepatocyte-phase Gadoxetic Acid-enhanced Magnetic Resonance Imaging: When Does It Become a Convenional HCC? Three-year Follow-up Study. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12.2, Chicago, USA.
          13. Morisaka H, Motosugi U, Sano K, Ichikawa T, Araki T:Non-Helical, Volumetric Dual-Energy CT Imaging with Area-Detector CT Scanner for Evaluating Hypervascular Hepatocellular Carcinoma. The 97th Scientific Assembly and Annual Meeting of Radiological Society of North America (RSNA), 2011. 11.27-12-2, Chicago, USA.
          14. Ichikawa T:Workshop “Diagnosis and manegement of HCC – the role of Primovist-enhanced MRI in guiding treatment strategy”. The 5th International Forum for Liver MRI, 2011. 9.16, Munich, Germany.